Article

Essay: Tackling antibiotic resistance

Department of Biology, 1001 E. Third Street, Indiana University, Bloomington, IN 47405, USA.
Nature Reviews Microbiology (impact factor: 21.18). 11/2011; 9(12):894-896. DOI:10.1038/nrmicro2693 pp.894-896

ABSTRACT The development and spread of antibiotic resistance in bacteria is a universal threat to both humans and animals that is generally not preventable but can nevertheless be controlled, and it must be tackled in the most effective ways possible. To explore how the problem of antibiotic resistance might best be addressed, a group of 30 scientists from academia and industry gathered at the Banbury Conference Centre in Cold Spring Harbor, New York, USA, from 16 to 18 May 2011. From these discussions there emerged a priority list of steps that need to be taken to resolve this global crisis.

0 0
 · 
1 Bookmark
 · 
62 Views
  • Article: Development of daptomycin for gram-positive infections.
    Journal of Antimicrobial Chemotherapy 11/2000; 46(4):523-6. · 5.07 Impact Factor
  • Article: Targeting virulence to prevent infection: to kill or not to kill?
    [show abstract] [hide abstract]
    ABSTRACT: Targeting components of the infectious process as a means to prevent infection has long been considered as an alternative to classic antimicrobial therapies. Although no clinically used drugs have yet emerged from these efforts, the dwindling supply of anti-infective treatment options within the physician's armamentarium has stoked a renewed interest in the identification and development of novel strategies to prevent infection.Section Editor:Gary Woodnutt – Diversa Corp., San Diego, CA, USAThere are multiple virulence factors that are required to initiate and maintain infection in the host. As many of these are external to the infecting cell, they provide clear target opportunities that would circumvent the need for cellular penetration. However, by definition, compounds that inhibit these targets would not kill the organism and thus many of the screening processes currently used will not be applicable. The difficulties associated with progressing targets of this type are discussed with some key examples of areas that might become clinical candidates in the near future. The suggestion that virulence inhibiting compounds might be less likely to generate resistance is intriguing but unproven. The lack of a clear path through regulatory bodies and the inability to test activity by traditional, and well accepted, clinical microbiology add to the complexity of achieving success with these novel interventions. However, as the clinical options for treatment of infectious disease are eroded by resistance the time might be ripe for exploiting these strategies.
    Drug Discovery Today Therapeutic Strategies 1(4):483-489.
  • Source
    Article: Human nutrition, the gut microbiome and the immune system.
    [show abstract] [hide abstract]
    ABSTRACT: Marked changes in socio-economic status, cultural traditions, population growth and agriculture are affecting diets worldwide. Understanding how our diet and nutritional status influence the composition and dynamic operations of our gut microbial communities, and the innate and adaptive arms of our immune system, represents an area of scientific need, opportunity and challenge. The insights gleaned should help to address several pressing global health problems.
    Nature 06/2011; 474(7351):327-36. · 36.28 Impact Factor

Keywords

30 scientists
 
Banbury Conference Centre
 
Cold Spring Harbor
 
discussions
 
effective ways possible
 
steps
 
universal threat